Guinea vs South Sudan: Population requiring preventive chemotherapy for schistosomiasis
Guinea
4.21 million
in 2024
South Sudan
3.75 million
in 2024
Guinea rank
20th
South Sudan rank
22nd
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea
- South Sudan
How they compare
Guinea currently reports 4.21 million against 3.75 million in South Sudan, a difference of 456,800.
That makes Guinea's figure about 1.1 times South Sudan's.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was South Sudan ahead.
Guinea ranks 20th and South Sudan ranks 22nd of 52 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.40 million | 2.57 million | 827,553 | Guinea |
| 2020s | 4.42 million | 3.48 million | 943,818 | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea or South Sudan?
- Guinea, at 4.21 million against 3.75 million in South Sudan as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea and South Sudan?
- 456,800, with Guinea ahead.
- How many years of comparable data are there for Guinea and South Sudan?
- 12 years are reported by both, from 2013 to 2024.
- How do Guinea and South Sudan rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea ranks 20th and South Sudan ranks 22nd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.